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Reversible protein phosphorylation is a signaling
mechanism involved in all cellular processes. To
create a systems view of the signaling apparatus in
budding yeast, we generated an epistatic miniarray
profile (E-MAP) comprised of 100,000 pairwise,
quantitative genetic interactions, including virtually
all protein and small-molecule kinases and phospha-
tases as well as key cellular regulators. Quantitative
genetic interaction mapping reveals factors working
in compensatory pathways (negative genetic interac-
tions) or those operating in linear pathways (positive
genetic interactions). We found an enrichment of
positive genetic interactions between kinases, phos-
phatases, and their substrates. In addition, we
assembled a higher-order map from sets of three
genes that display strong interactions with one
another: triplets enriched for functional connectivity.
The resulting network view provides insights into
signaling pathway regulation and reveals a link
between the cell-cycle kinase, Cak1, the Fus3 MAP
kinase, and a pathway that regulates chromatin
integrity during transcription by RNA polymerase II.
INTRODUCTION
Phosphate-based signaling is critical to almost all major cellular
processes and is ubiquitously present across archea, prokar-
yota, and eukaryota (Kannan et al., 2007). Systems-wide studies
in the post-genome era have provided unprecedented informa-
tion about the activities of signaling proteins (Johnson and
Hunter, 2005), and several thousand sites of protein phosphory-
lation have been mapped using mass spectrometry (Ficarro952 Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc.et al., 2002; Green and Pflum, 2007; Lee et al., 2006; Matsuoka
et al., 2007; Olsen et al., 2006). The knowledge of kinase-
substrate relationships has been expanded by both in vitro
protein chip analysis (Ptacek et al., 2005) and large-scale genetic
screens using a kinase overexpression strategy (Sopko et al.,
2006). Bioinformatic efforts have focused on network-level anal-
yses of phosphorylation, providing database resources for phos-
phorylation sites and signaling pathways (Diella et al., 2008; Lee
et al., 2006; Zanzoni et al., 2007). In addition, the integration of
context-dependent information (including protein interactions
and cell-specific kinase expression) has helped to improve the
specificity of phospho-consensus site assignments (Linding
et al., 2007).
Despite these achievements, signaling networks have re-
mained difficult to study. While phosphoproteomic datasets illu-
minate the magnitude and diversity of protein phosphorylation,
the functional relevance for themajority of these phosphorylation
sites remains unknown (Johnson and Hunter, 2005). Focused
studies can elucidate the function of one specific kinase or one
particular pathway but often overlook important connections to
components that do not directly participate in the pathway. In
particular, two hallmarks of kinase signaling are the linear
cascades of kinases important for signal amplification and the
abundant crosstalk between these pathways in order to coordi-
nate multiple cellular inputs/outputs.
Genetic interactions report on the extent to which the function
of one gene depends on the presence of a second gene and can
illuminate the functional organization of protein networks. Nega-
tive genetic interactions (n; synthetic sick/lethal interactions)
describe cases where two mutations in combination cause
a stronger growth defect than expected from the two single
mutations. In contrast, positive genetic interactions (p) corre-
spond to cases where the double mutant is either no sicker
(epistatic) or healthier (suppressive) than the sickest single
mutant (Figure 1A). Negative genetic interactions are often found
for proteins that work in compensatory pathways, while positive
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Figure 1. Epistasis Analysis of the Yeast Signaling Machinery
(A) The entire spectrum of genetic interactions. Genetic interactions range from negative (e.g., synthetic sick) to positive (e.g., suppression) where the growth rate
of the double mutant is either less ((aDbD) < (aD)(bD)) or greater ((aDbD) > (aD)(bD)) than the product of the growth rates of the corresponding single mutants,
respectively. As shown in the distribution curve of our dataset, significantly negative (S% 2.5) and positive (SR 2.0) genetic interactions are rare.
(B) Composition of the signaling E-MAP. For a full list of genes analyzed in this study, see Table S1.interactions can identify pairs of proteins that are in the same
complex and/or function in the same pathway (Collins et al.,
2007b; Kelley and Ideker, 2005; Roguev et al., 2008; Schuldiner
et al., 2005; St. Onge et al., 2006). Two approaches, synthetic
genetic array (SGA) technology (Tong et al., 2001) and diploid
based synthetic lethality analysis on microarrays (dSLAM) (Pan
et al., 2004), have been developed to identify synthetic sick/
lethal (SSL) relationships on a genome-wide scale in S. cerevi-
siae. SSL interactions, however, only represent a subset of the
full epistatic interaction spectrum. Our interest in mapping the
pathway architectures involved in phosphate-based signaling
led us to use an SGA-based methodology that measures the
entire range of epistatic relationships, termed epistatic miniarray
profile (or E-MAP) (Figure 1A) (Collins et al., 2006, 2007a; Roguev
et al., 2008; Schuldiner et al., 2005, 2006; Wilmes et al., 2008).
The E-MAP method does not rely on the detection of individual
phosphoproteins, but it rather provides the functional connec-
tions between signaling molecules, whether these are direct or
indirect. In addition, genetic interactions are not limited to the
detection of proteins in physical contact and are thus particularly
useful in identifying more transient interactions and those
controlled by posttranslational modification. Here we use our
E-MAP approach to provide an unbiased, genetic overview of
the functional connections within the signaling machinery.
RESULTS AND DISCUSSION
Composition of the Signaling E-MAP
An E-MAP quantitatively records genetic interactions between
pairs of mutations for a defined subset of genes. The data are
generated by systematically constructing double mutant strains,
measuring their growth rates, and converting this information to
individual genetic interaction scores, both positive and negative
(Collins et al., 2006; Schuldiner et al., 2006). To explore the
signaling apparatus of S. cerevisiae, our genetic approach tar-geted almost all known protein kinases (121) and phosphatases
(38) and their regulatory proteins (45 and 39, respectively), as
well as non-protein kinases (47) and phosphatases (38)
(Figure 1B, Table S1 available online). To include those compo-
nents of the signaling machinery that are essential for viability,
we employed the DAmP (decreased abundance by mRNA
perturbation) strategy to create 48 hypomorphic alleles. This
method relies on the insertion of an antibiotic-resistance marker
to disrupt the natural 30UTR, which leads to destabilization of the
mRNA transcripts and, subsequently, lowered protein levels
(Schuldiner et al., 2005). In all, the signaling E-MAP contains
483 genes, including 135 genes that serve as reporters of
a variety of major biological processes (Figure 1B, Table S1).
We comprehensively evaluated the pairwise genetic interactions
of these 483 alleles, resulting in approximately 100,000 distinct,
pairwise genetic interaction measurements (Figure S1, Table
S2). All data are available at http://interactome-cmp.ucsf.edu
in an interactive and searchable format.
Superposition of Literature-Derived Network
with Signaling E-MAP
To evaluate the genetic interaction data, we first examined how
the data recapitulated known phosphorylation/dephosphoryla-
tion events. To this end, we manually curated from the literature
the majority of well-characterized kinase- and phosphatase-
substrate relationships (654 and 141, respectively) (Figures 2A
and S2, Table S3). Of these 795 pairwise connections, our
E-MAP contained data for 252 (32%) of them (Table S4). We
analyzed the genetic interaction patterns for different subsets
of the manually curated set of known phosphorylation events:
kinases and their substrates, phosphatases and their substrates,
two kinases that share the same substrate, two phosphatases
that share the same substrate, and kinase-phosphatase pairs
that target a common substrate (Figure 2B, Tables S4 and S5).
As a metric to describe the trends within these different subsets,Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc. 953
AB
Figure 2. Comparison of the Literature-Derived Signaling Network to the Genetic Interaction Data
(A) A network diagram of characterized phosphorylation and dephosphorylation events between kinases and their substrates (green arrows) and phosphatases
and their substrates (red arrows), manually curated from the literature (see Table S2). Below this are specific examples of kinase-substrate (1) and phosphatase-
substrate relationships (2) and cases where two kinases (3), two phosphatases (4), or one kinase and one phosphatase (5) target one or more substrates. Blue
and yellow edges correspond to negative and positive genetic interactions, respectively. The thickness of the edge correlates with the strength of the genetic
interaction. See Figure S2 for an enlarged view of this network.
(B) Ratios of highly positive (SR 2.0) to negative (S%2.5) genetic interactions (p to n ratio). Above dashed line: The p to n ratios of previously published datasets
(early secretory pathway [ESP] [Schuldiner et al., 2005] and chromosome function [Collins et al., 2007b]), the signaling E-MAP, only protein kinases and protein
phosphatases (K versus K or P versus P), and protein kinases versus protein phosphatases (K versus P) are presented. Below dashed line: The p to n ratios for
known kinase-substrate and phosphatase-substrate pairs (K/ S, P/ S) (out of these 252 relationships that we genetically tested, we observed significant
genetic interactions [positive and negative] for 25 of them [10%]) as well as kinase-kinase, phosphatase-phosphatase (K,K/ S; P,P/ S), and kinase-phos-
phatase pairs (K,P/ S) that share one or more substrates are shown. To obtain these ratios and subsequent p values, we also included regulatory subunits
known to direct kinase/phosphatase activity toward specific substrates (see Experimental Procedures and Table S3).we employed a ratio of highly positive (SR 2.0) to negative (S%
2.5) genetic interactions (p to n ratio) (S = genetic interaction
score). Importantly, the relative ratios obtained for the different
subsets were independent of the thresholds used to define the
positive and negative genetic interactions (data not shown).954 Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc.The E-MAP data revealed a significant enrichment of positive
genetic interactions for known kinase- and phosphatase-
substrate pairs. While the E-MAP as a whole displayed a p to n
ratio of 0.53, this ratio was almost inverted for characterized
kinase-andphosphatase-substrate relationships (p ton ratio: 1.78;
p value = 1.83 103) (Figure 2B, Tables S1–S5). For example, we
detected positive genetic interactions between the CAK1 kinase
and two of its substrates, CTK1 and SMK1 (Figure 2A, 1) (Osta-
penko and Solomon, 2005; Schaber et al., 2002). These trends
might be rationalized as follows: if the phosphorylated form of a
substrate is important for cell growth, then either mutation of
the substrate or loss of its phosphorylation through mutation of
the cognate kinase will result in impaired cell growth. Once the
kinase has been deleted (and the level of substrate phosphoryla-
tion has decreased), additional deletion of the substratewill result
in a less severe growth defect than expected from the two single
mutations, thus giving rise to a positive genetic interaction.
Similar logic can be applied to phosphatase-substrate relation-
ships that display positive genetic interactions (e.g., SIT4-
GCN2 [Cherkasova and Hinnebusch, 2003] or SIT4-SAP155
[Luke et al., 1996], Figure 2A, 2) if the dephosphorylated form of
a substrate is important for cell growth. Conversely, pairs of
kinases (or phosphatases) that act on the same substrate can
display negative interactions between themselves if they are
partially or completely redundant. Indeed, we observed an
enrichment of negative genetic interactions in these cases (p to
n ratio: 0.21; p value = 2.53 103) (Figure 2B, Table S5), including
a negative interaction between the CLA4 and STE20 kinases,
both ofwhichphosphorylateMyo3 (Wuet al., 1997), andbetween
PPH21 and PPH22, duplicated PP2A phosphatase family
members known to act redundantly on a number of different
substrates (Figure 2A, box 3 and box 4) (Oficjalska-Pham et al.,
2006).
The most striking p to n ratio was observed for kinase-phos-
phatase pairs that target a common substrate. These pairs of
counterbalancing enzymes proved to be much more likely to
display positive genetic interactions (p to n ratio: 5.5; p value =
2.83 103) (Figure 2B, Table S5). For example, a positive genetic
interaction was observed between deletions of the SNF1 kinase
and the phosphatase SIT4, both of which regulate the phosphor-
ylation status of the Gln3 transcription factor (Figure 2A, box 5)
(Bertram et al., 2002; Tate et al., 2006; Wang et al., 2003). In
these cases, if optimal cell growth requires a substrate to main-
tain a particular level of phosphorylation, then mutation of its
phosphatase (or kinase) will perturb the steady-state phosphor-
ylation levels, resulting in a growth phenotype. By additionally
deleting the counterbalancing kinase (or phosphatase), wild-
type phosphorylation levels may be restored, and the growth
defect may be suppressed. We therefore contend that this quan-
titative genetic platform can be used to identify kinase-substrate
pairs, phosphatase-substrate pairs, and kinase pairs, phospha-
tase pairs, and kinase-phosphatase pairs that share a common
substrate (see Tables S2 andS6 for complete list of genetic inter-
actions).
While we found a significant enrichment of positive interac-
tions within the set of kinase-substrate, phosphatase-substrate,
and kinase-phosphatase pairs that share a common substrate,
many of the literature-curated relationships were not captured
by our genetic analysis (Table S5). There are several reasons
why we would not expect a perfect correlation between these
two datasets. First, many signaling pathways are only fully acti-
vated in response to a particular stimulus (e.g., high salt/Hog1).
Since our genetic interaction screen was carried out under stan-dard growth conditions, most pathways were only operating at
basal levels. As a result, their perturbation may not yield a signif-
icant growth phenotype.GeneratingE-MAPdata under a number
of different stresses would help detect many of these stimulus-
specific genetic interactions. Second, there are many duplicated
copies of kinases or phosphatases that exist in the yeast
genome (e.g., MKK1 and MKK2), and this redundancy can
mask potential genetic interactions. In these cases, triple
mutants could provide richer interaction profiles and help identify
additional connections. Despite these limitations, we detected
a significant number of genetic interactions that correlated with
previously described network connections, illustrating the
predictive power of this dataset.
To investigate the characteristics of genetic interactions
among components of the signaling apparatus, we analyzed
the p to n ratio among andbetween the protein kinases andphos-
phatases. Compared to previous datasets, including an
E-MAP of chromosome function (Collins et al., 2007b) that had
a p to n ratio of 0.49, we found that there was a large enrichment
of positive genetic interactions within the set of protein kinases
and protein phosphatases (K versus K/P versus P) (p to n ratio:
0.78; p value = 1.0 3 103) and between protein kinases and
protein phosphatases (K versus P) (p to n ratio: 0.87; p value =
5.13 103) (Figures 2B andS3, Table S5). The trend toward posi-
tive genetic interactions could stem from the fact that kinasesand
phosphatases often work together in linear pathways.
Signaling E-MAP Reveals Factors Involved in Histone
Htz1 Deposition and Acetylation
To test the predictive power of the E-MAP data, we examined
the positive genetic interactions we identified with the histone
H2A variant, HTZ1. Htz1 is incorporated into chromatin by the
SWR-C chromatin-remodeling complex (Korber and Horz, 2004)
and is subsequently acetylated on its amino terminus by the
histone acetyltransferase, NuA4 (Babiarz et al., 2006; Keogh
et al., 2006b; Millar et al., 2006). Consistent with this, HTZ1 dis-
played positive genetic interactions with SWR1 (+3.5), the cata-
lytic subunit of SWR-C, as well as with VPS71 (+3.9) and VPS72
(+3.5), two other components of the complex (Figure 3A). Signif-
icant positive interactions were also observed with other factors
not previously known to function with Htz1. These included
Bud14, a regulatory subunit for the phosphatase Glc7 (Cullen
and Sprague, 2002), and Clb2, a B-type cyclin that regulates
Cdc28 (CDK) activity (Cullen and Sprague, 2002; Rua et al.,
2001) (Figure 3A). Deletion of either BUD14 or CLB2 resulted in
a marked decrease in Htz1 lysine 14 acetylation (Htz1-K14Ac;
Figure 3B), indicating that these proteins impinge on the abun-
dance of a chromatin-associated form of this histone variant
(Keogh et al., 2006b). Fractionation experiments determined
that deletion of BUD14 resulted in almost a 3-fold decrease in
nuclear Htz1, which correlated with the decrease (4-fold) in
the K14-acetylated form of the histone (Figure 3C). The Bud14-
associated phosphatase Glc7 has been shown to impinge on
chromatin structure by dephosphorylating serine 10 of histone
H3, a mark linked to chromosome transmission (Hsu et al.,
2000). Therefore, Glc7/Bud14 may regulate Htz1 incorporation
by SWR-C into chromatin, either directly or indirectly, potentially
through histone H3 (Figure 3D).Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc. 955
Conversely, the effect of clb2D was primarily seen at the level
of Htz1 acetylation. Here the levels of nuclear Htz1 were unper-
turbed by deletion of CLB2, but Htz1-K14Ac was decreased
3-fold (Figure 3C). This implies that Clb2 exerts a regulatory func-
tion on NuA4, the enzyme complex that adds this acetylation
mark (Figure 3D). An independent study determined that Yng2,
a component of NuA4 required for its histone acetyltransferase
activity (Krogan et al., 2004), is a target of Clb2-dependent
Cdc28 phosphorylation on two consensus CDK sites (T185
and S188) (L. Holt, J. Villen, S. Gygi, and D. Morgan, personal
communication). This connection is also in agreement with
previous reports that suggested that Htz1 function is cell cycle
regulated (Dhillon et al., 2006). Although further work will be
required to resolve the mechanistic details of Htz1 regulation,
these data confirm the predictive power of individual positive
genetic interactions from the E-MAP.
Mapping Genetic Interactions onto Characterized
Signaling Pathways
We next explored how the genetic interactions mapped within
signaling cascades, involving multiple kinases and/or phospha-
tases. The HOG (high osmolarity glycerol) pathway is a well-
characterized MAP kinase cascade that controls the response




Figure 3. Identification of Factors Involved
in Histone Htz1 Deposition and Acetylation
(A) Full spectrum of HTZ1 genetic interactions.
Genes with the strongest positive genetic interac-
tions are highlighted.
(B) clb2D or bud14D profoundly reduce the total
pool of Htz1-K14Ac. Whole-cell extracts were iso-
lated from isogenic strains containing Htz1 with
a C-terminal HA3-tag, resolved by SDS-PAGE,
and immunoblotted as indicated. Rpn8 was used
as a loading control.
(C) bud14D reduces both chromatin-associated
Htz1 and Htz1-K14Ac, while clb2D specifically
reduces the latter pool. Isogenic strains containing
Htz1.HA3 were separated into T(otal), C(ytoplas-
mic), or N(uclear) fractions and immunoblotted
with the indicated antibodies. Enrichment of the
proteasome component Rpn8 and the chromatin
component H2B in appropriate fractions (soluble
cytoplasm and insoluble nucleus) demonstrates
efficient separation. Using the H2B levels as
a loading control, Htz1-K14Ac was decreased 3.7-
and 3.0-fold in bud14D and clb2D, respectively.
By comparison, nuclear Htz1 was decreased 2.7-
fold in bud14D but comparable to WT in clb2D.
(D) Schematic illustration of Htz1 deposition by
SWR-C and acetylation by NuA4. The potential
points of action of Bud14 and Clb2 in this pathway
are indicated.
of the pathway is activated by the Sln1
osmosensor, which leads to activation
of two MAP kinase kinase kinases
(MAPKKKs), Ssk2 and Ssk22. These two
kinases then phosphorylate a dedicated
MAP kinase kinase (MAPKK), Pbs2, which in turn dually phos-
phorylates and activates the MAP kinase (MAPK) Hog1. Under
iso-osmotic conditions, the pathway is downregulated by the
Ypd1 phosphotransferase and Ptc1, a phosphatase that,
together with its scaffolding protein Nbp2, controls Hog1
dephosphorylation (Figure 4A). Mutations of these negative
regulators (YPD1, PTC1, and NBP2) primarily display positive
genetic interactions with the activating proteins in the pathway
(Figure 4B), presumably suppressive relationships that counter-
balance the levels of phosphorylation in the pathway. In contrast,
the genes coding for protein phosphatases that control Hog1
basal and maximal activity (PTC1, PTC2, PTC3, PTP2, PTP3)
show largely negative genetic interactions among themselves
(Figure 4B), suggesting a certain degree of redundancy.
In addition to the direct genetic interaction score between
gene pairs, each gene possesses a genetic interaction profile
that describes its interactions with all other genes in the
E-MAP (see http://interactome-cmp.ucsf.edu [2008]). The
genetic interaction profile provides a high-resolution phenotype,
and functionally related genes often have similar interaction
profiles. For example, hog1D and pbs2D showed themost highly
correlated profiles among the HOG pathway genes, indicating
that they are the most functionally related pair of proteins in this
pathway (Figure 4C). Also correlated, but to a lesser extent, are956 Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc.
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Figure 4. Mapping Genetic Interaction Data onto Known Signaling Pathways
(A) General schematic of the Sln1 branch of the HOGpathway. Protein kinases and phosphatases are denoted as green and red, respectively, while green and red
arrows correspond to phosphorylation and dephosphorylation actions, respectively.
(B) The negative pathway regulators YPD1, PTC1, and NBP2 show strong positive genetic interactions with the pathway activators SSK1, SSK2, SSK22, PBS2,
and HOG1. In contrast, genes coding for the protein phosphatases (PTC1, PTC2, PTC3, PTP2, and PTP3) acting on Hog1 show primarily negative genetic inter-
actions among themselves.
(C) Scatter plot of the correlation coefficients of pbs2D and hog1D with all genetic profiles in the signaling E-MAP.
(D) Schematic illustration of the inositol polyphosphate biosynthetic pathway.
(E) A subset of genetic interactions for PLC1, KCS1, IPK1, and VIP1. In (B) and (E), negative and positive genetic interactions are indicated by blue or yellow
squares, respectively. Gray squares represent genetic interactions not tested.ssk1D and ssk2D, whichwebelieve is due to the fact that Pbs2can
alsobe activated byanalternativeMAPKKK,Ste11 (O’Rourke and
Herskowitz, 2004). Interestingly, ssk2D is more highly correlated
with hog1D and pbs2D when compared to ssk22D (Figure 3C),
which suggests that Ssk2 is the predominant MAPKKK for
pathway activation under the growth conditions of our assay.
Consistently, the interactions of ssk2D with genes encoding the
negative pathway regulators Ypd1, Ptc1, and Nbp2 are much
more positive than those seen with ssk22D (Figure 4B). Overall,
the information encapsulated within both the individual pairwise
scores and the correlation coefficients between the genetic inter-
action profiles can be used to resolve pathway architecturesmore
powerfully than any single observation.
The signaling E-MAP also contains the majority of small-mole-
cule kinases and phosphatases (Figure 1B, Table S1), including
several enzymes involved in inositol polyphosphate metabolism.
Inositol phosphate signaling is initiated by the phospholipase
Plc1, resulting in the formation of IP3, which is converted to IP5
by Ipk2, then to IP6 by Ipk1 (Figure 4D) (Alcazar-Roman and
Wente, 2008). IP6 can subsequently become diphosphorylatedby Kcs1 or Vip1 to respectively yield the IP7 metabolites, 5-PP-
IP5 or 4/6-PP-IP5 (Figure 4D) (Mulugu et al., 2007; Saiardi et al.,
2004). Genetic analysis of these enzymes (except for ipk2D,
which had mating and sporulation defects) revealed that all
members of the pathway displayed positive genetic interactions
with each other, except for VIP1 and KCS1 (Figure 4E). This is
consistent with a linear pathway for the synthesis of IP6, which
then branches to yield the different IP7 metabolites (Figure 4D)
(Alcazar-Roman and Wente, 2008). Although the overall genetic
interaction profiles for these four enzymes are similar, there are
almost no examples where all four enzymes display the same
interactions with a given mutant. For example, all components
except VIP1 display strong negative interactions with the cyclin
CLB2 and PPH3, a phosphatase linked to cell-cycle progression
(Keogh et al., 2006a). Since Plc1, Ipk1, andKcs1—but not Vip1—
are involved in the synthesis of the 5-PP-IP5 metabolite, these
data may imply a functional connection of the 5-PP-IP5 metabo-
lite with CLB2 and PPH3. Furthermore, only PLC1 and IPK1
showed positive genetic interactions with ELP2 and ELP3, two
proteins linked to transcriptional elongation and tRNA functionCell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc. 957
(Svejstrup, 2007), which suggests that PLC1 and IPK1, or the
metabolites they synthesize, impinge on those processes
(Figure 4E). Our results concur with recent evidence that specific
inositide metabolites are involved in distinct cellular functions
(Alcazar-Roman and Wente, 2008) and thus give rise to a wide
range of genetic interaction patterns.
Overall, the inositol polyphosphate and MAP kinase cascades
are two examples where the signaling E-MAP supports previ-
ously described network connections and provides additional
functional insight into these well-characterized pathways.
Analysis of ‘‘Triplet Genetic Motifs’’
With the goal of extracting previously unrecognized pathway
connections, we further analyzed the genetic interaction data
by extracting triplet motifs (Chechik et al., 2008). In these ‘‘triplet
genetic motifs’’ (or TGMs), sets of three genes were mutually
connected to each other by positive (SR 2.0) or negative (S%
2.5) genetic interactions.
Triplet motifs are the simplest motifs, apart from binary pair-
ings, and we propose that gene triplets displaying genetic inter-
actions are very likely to be functionally connected. There are




Figure 5. Triplet Genetic Motifs from the
Signaling E-MAP
(A) A schematic of the four types of triplet genetic
motifs (TGMs): all three positive (type I); two posi-
tive, one negative (type II); one positive, two nega-
tive (type III); and all three negative (type IV).
(B) A network diagram of all TGMs involving three
kinases using highly negative (S%2.5) and posi-
tive (SR 2.0) genetic interactions. The motifs were
connected if they shared one or two nodes; blue
and yellow edges correspond to negative and
positive genetic interactions, respectively. The
thickness of the edges is correlated with the
strength of the genetic interaction. TGMs high-
lighted in gray are discussed in the text.
(C) Comparison of the ratio of the four types of
TGMs that contain one ormore kinase or phospha-
tase. The ratios are obtained by normalizing the
number of genetic triplet motifs within each set
(i.e., types II, III, and IV) to the number of TGMs
that are all positive (type I). For a complete list of
all TGMs, see Table S5.
positive (type I); twopositive, one negative
(type II); one positive, two negative (type
III); and all three negative (type IV)
(Figure 5A). Using only the genes coding
for protein kinases, we generated each
type of TGM (Table S7) and assembled
a network diagram where the motifs
were connected if they shared one or
two nodes (Figure 5B). We posit that
TGMs comprised of three positive genetic
interactions (type I) will be enriched for
factors functioning in the same pathway,
whereas all negative TGMs (type IV)would
potentially correspond to genes functioning in three distinct,
redundant pathways (Figure 5A). Type II (++) and type III
(+) TGMs represent intermediate cases. For example, a type
II TGM was observed for PTK2, HAL5, and SAT4, three kinases
that are all involved in modulating the major electrogenic trans-
porters of yeast (Pma1, Trk1, Trk2) (Figure S4) (Goossens et al.,
2000; Mulet et al., 1999). Ptk2 phosphorylates and activates the
H+-ATPase Pma1, thereby increasing the electrical membrane
potential, while the Trk1,2 K+ transport system is positively regu-
lated by Hal5 and Sat4 kinases and is a major consumer of elec-
trical potential. Together, these two systems determine the
steady-state membrane potential and thereby regulate
secondary active transport systems. Due to their partial redun-
dancy, HAL5 and SAT4 showed a negative genetic interaction;
however, both genes displayed positive genetic interactions
with PTK2, likely a suppressive relationship between the gener-
ator and the consumers of themembrane potential. Interestingly,
the PTK2-HAL5 edge displayed negative genetic interactions
with PBS2 (resulting in a type III TGM) (Figure S4), which illus-
trates how cells with a compromised ability to control ion homeo-
stasis are unable to tolerate an additional mutation in a separate/
parallel pathway that is important for responding to salt stress.958 Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc.
The three kinases most frequently found in TGMs were CLA4,
which has been functionally linked to cytokinesis (12 TGMs);
BUB1, which is essential for proper spindle checkpoint function
(13 TGMs); and the AMP-activated kinase SNF1, required for
glucose-repressed transcription and thermotolerance (14
TGMs) (Figure 5B). These three kinases were also the most
genetically promiscuous when we extended this analysis to the
other genes on the signaling E-MAP (Figure S5), suggesting
that they occupy central signaling nodes in budding yeast.
Consistent with the pattern observed with the pairwise genetic
interactions (Figures 2B and S3), we found an overall enrichment
of positive genetic interactions among and between kinases and
phosphatases participating in the TGMs. When the TGMs were
restricted to contain only kinases and phosphatases, we found
an approximately equal number of the four types of motifs
(Figure 5C). As non-kinase/phosphatase genes were introduced,
the proportion of TGMs with positive genetic interactions
decreased (Figure 5C).
Cak1 and Fus3 Kinases Function in the Set2/Rpd3C(S)
Pathway
To uncover previously uncharacterized signaling pathways, we
next focused on the type I (+++) TGM, where only one protein
is required to be either a kinase or phosphatase. We assembled
a type I TGM list, restricted to factors that were not physically
associated (purification enrichment scores <0.2 [Collins et al.,
2007a]) since we wanted to enrich for pathways rather than
protein complexes. Taking the 47 most significant type I
TGMs, as defined by the product of their three individual genetic
interaction scores, we assembled a network diagram (Figure S6)
to identify regions containing high-density, positive genetic inter-
actions. Several such clusters were discovered, including the
SET2-CAK1 pair, which showed positive genetic interactions
with CTK1, CTK2, EAF3, ADO1, and FUS3 (Figures 6A and
S6). Several of these proteins have previously been demon-
strated to act together in a pathway that is required for efficient
transcriptional elongation by RNA polymerase II (RNAPII). In
this cascade, the kinase Ctk1 (with its regulatory proteins Ctk2
and Ctk3) phosphorylates Rpb1, the largest subunit of RNAPII,
on its C-terminal domain (Cho et al., 2001). This modification
recruits the methyltransferase Set2 to methylate Lys36 of
histone H3 during transcriptional elongation (Hampsey andRein-
berg, 2003). This mark, in turn, recruits Eaf3, a component of
the Rpd3C(S) histone deacetylation complex, which then deace-
tylates histones H3 and H4 in the coding regions of genes, re-
sulting in chromatin compaction, an event that ultimately
suppresses spurious cryptic initiation (Carrozza et al., 2005;
Joshi and Struhl, 2005; Keogh et al., 2005).
Since CAK1 displayed positive genetic interactions with
multiple factors implicated in this pathway, we predicted that it
would be an integral component of the RNAPII transcriptional
elongation control process. The positive genetic interactions of
CAK1 with SET2 and EAF3 were confirmed by tetrad analysis
and spot testing, which showed that eaf3D and set2D sup-
pressed the slow growth phenotype observed in a cak1-DAmP
background (Figure 6B). In contrast, the positive genetic interac-
tion between CAK1 and CTK1 corresponded to an epistatic
interaction since the double mutant was no sicker than eitherof the two single mutants (Figure S7B). To validate the genetic
interaction observed between CAK1 and CTK1, we expres-
sion-profiled bothmutants using DNAmicroarrays. This revealed
a very significant overlap in mRNA expression of genes affected
in either mutant, implying that these two kinases function
together in vivo (Figure S7C, Table S8). Furthermore, out of
a large collection of kinase mutant expression profiles, the
ctk1D profile was most similar to that of the cak1-DAmP strain
(S.v.W. and F.C.P.H., unpublished data).
Finally, the cak1-DAmP strain, aswell as other previously char-
acterized CAK1 mutants (cak1-22, cak1-23, cak1-95) (Espinoza
et al., 1998), showed a significant increase of transcription initia-
tion from a cryptic internal TATA site within FLO8 (Figure 6C). A
similar phenotype has previously been observed with set2D
and deletions of the chromatin assembly factors SPT2 and
HIR1 (Figure 6C) (Carrozza et al., 2005; Kaplan et al., 2003; Nour-
ani et al., 2006). In agreement with these data, Ostapenko and
Solomon reported that Cak1 phosphorylates Ctk1 in vivo (Osta-
penko and Solomon, 2005), and we found that deletion of CTK1
(or CTK2 and CTK3) also results in a cryptic initiation defect (Fig-
ure 6E) (Cheung et al., 2008; Youdell et al., 2008).
Interestingly Bur1, a kinase known to suppress spurious tran-
scription initiation, is another well-characterized Cak1 substrate
(Yao and Prelich, 2002). We previously showed that deletion of
SET2 or EAF3 suppressed the lethality associated with bur1D
(Keogh et al., 2005), suggesting crosstalk between the two path-
ways (Figure 6D). The negative genetic interaction between
CAK1 and BUR1 (Figure S7D) suggests that Bur1 is involved in
another, parallel pathway. Overall these data demonstrate that
Cak1 acts as a key regulator controlling two kinase cascades
involved in regulating intergenic chromatin integrity (Figure 6D).
Both CAK1 and SET2 also displayed positive genetic interac-
tions with FUS3, a MAP kinase involved in the mating pathway
(Figure 6A). Further testing revealed that fus3D gave rise to
a cryptic initiation defect as well (Figure 6E). Other factors known
to work with FUS3 in the mating pathway (KSS1, STE50, DIG2)
(Chen and Thorner, 2007) or other MAP kinases (HOG1 and
SLT2) did not display positive genetic interactions with CAK1
and SET2 and accordingly did not have the same transcriptional
defect (Figure 6E). Work by Young and colleagues demonstrated
that Fus3 localizes to actively transcribed genes by chromatin
immunoprecipitation (Pokholok et al., 2006). Taken together with
the genetic interaction data, these findings imply that Fus3 may
phosphorylate one or more chromatin factors involved in sup-
pressing cryptic initiation. Further work will be required to reveal
the mechanistic details of this intriguing connection between the
mating pathway and transcriptional chromatin integrity.
Perspective
In summary, we have systematically and quantitatively mapped
the pairwise genetic interactions within the yeast signaling
machinery. The entire genetic interaction matrix of 100,000 pair-
wise interactions is available in a web-based searchable format,
as illustrated in Figure S8, at http://interactome-cmp.ucsf.edu/.
We have analyzed the quantitative genetic interaction data using
TGMs, which we show can be a powerful approach for globally
studying signaling pathways and uncovering mechanistic details





Figure 6. The Cak1 Kinase Functions in the Ctk1/Set2/Rpd3C(S) Pathway that Suppresses Cryptic Initiation by RNA Polymerase II
(A) Subset of type I TGMs that share the Cak1-Set2 positive genetic interaction. For a complete picture of all type I TGMs see Figure S6.
(B) Tetrad analysis and serial 10-fold dilution spot testing demonstrates that the slow growth of the cak1-DAmP allele is strongly suppressed by set2D or eaf3D.
(C) CAK1 suppresses cryptic transcription initiation. TheGAL1-FLO8-HIS3 reporter (Nourani et al., 2006) is described in the Experimental Procedures. The HIS3
gene product is only produced when transcription aberrantly initiates from a cryptic promoter within FLO8 (Carrozza et al., 2005; Joshi and Struhl, 2005; Keogh
et al., 2005). His3 expression was monitored by 10-fold dilution spotting of the indicated strains onto synthetic complete (SC) medium ± histidine with galactose/
raffinose (2%/1%, respectively) as the carbon source. The lower panels employed a series of cak1 temperature-sensitive alleles (Espinoza et al., 1998) at their
semipermissive temperature (SC, 32C, 48 hr; HIS, 32C, 96 hr).
(D) Possible schematic of this pathway controlling intergenic chromatin fidelity.
(E) The MAP kinase Fus3 regulates cryptic initiation. All strains contain a GAL1Sp-FLO8-HIS reporter, similar to that in Figure 6C (see Experimental Procedures).
Reporter strains were pinned in duplicate onto SC-HIS with galactose/raffinose as the carbon source, incubated at 30C, and photographed on days indicated.
Panels are standardized to facilitate crosscomparison of reporter expression in each strain/time point.960 Cell 136, 952–963, March 6, 2009 ª2009 Elsevier Inc.
dataset, when integrated with other genome-wide datasets, will
help to understand and model the phosphate-based signaling
behavior of yeast cells. Furthermore, this signaling E-MAP also
provides a launching platform for other analyses. While the
current screen was carried out on rich media, many signaling
pathways depend on specific stimuli. Condition-dependent
screens will, therefore, reveal dynamic changes in the signaling
apparatus. We also plan to compare the genetic interaction
profiles of complete kinase gene deletions with those of catalyt-
ically dead mutants and analog-sensitive kinase alleles (Bishop
et al., 2000). Such analyses should allow us to separate the cata-
lytic activities from the scaffolding functions of these proteins.
Comparison of the genetic architecture of the signaling networks
between different yeast species (Roguev et al., 2008) and higher
organisms (Bakal et al., 2008) will be instructive in understanding
how regulation via reversible phosphorylation is conserved and
how it has evolved. Finally, epistasis analyses have significant
potential, not only for functionally connecting proteins into path-
ways and complexes but also for identifying combinations of
genes, or genes operating at critical nodes at the intersection
of signaling pathways, that can serve as appropriate therapeutic
targets.
EXPERIMENTAL PROCEDURES
Strain construction, E-MAP experiments, and scoring of genetic interactions
(S scores) were performed as previously described (Collins et al., 2006,
2007b; Schuldiner et al., 2005). To highlight strong genetic interactions, we
introduced a cutoff of S%2.5 for negative interactions and SR 2.0 for posi-
tive interactions. Positive to negative (p to n) ratios were computed for the
subsets depicted in Figure 2A. The sets consisting of kinase and phosphatase
pairs that act on the same substrates were compared with a subset of the
signaling E-MAP that contains only kinases, phosphatases, and regulatory
subunits. Two-tailed p valueswere computed using Fisher’s exact test. The re-
maining sets in Figure 2A were compared with the chromosome function
E-MAP. Here, two-tailed p valueswere computed using chi-square with Yates’
correction. Importantly, the relative ratios obtained were independent of the
thresholds used to define the positive and negative genetic interactions
(data not shown). Kinases, phosphatases, kinase-substrate pairs, and phos-
phatase-substrate pairs are listed in Tables S3–S5.
The preparation of yeast whole-cell extracts by trichloroacetic acid (TCA)
(Figure 3B) and cell fractionation experiments (Figure 3C) was performed
essentially as described (Keogh et al., 2006b). The GAL1-FLO8-HIS3 reporter
(Figure 6C) consists of (1) the FLO8 promoter replaced by that of galactose-
regulated GAL1/10 and (2) the HIS3 gene inserted out of frame into FLO8
(flo8D (+1729-2505)::HIS3 (+1–663)) such that HIS3 product is only translated
when transcription initiates from a cryptic promoter within FLO8 (Nourani et al.,
2006). In the almost identical GAL1Sp-FLO8-HIS reporter (Figure 6E), GAL1Sp
is an attenuated version of the GAL1 promoter, missing 1.5 copies of the 50
GAL4-UAS (Mumberg et al., 1994). Reporter strains (Table S9) were created
by direct transformation or mating followed by tetrad dissection. HIS3 expres-
sion was monitored by spotting the appropriate strains onto synthetic
complete (SC) medium ± histidine with either glucose (2%) or galactose/raffi-
nose (2%/1% respectively) as the carbon source.
Gene expression profiling was carried out as previously described (van de
Peppel et al., 2005). p values for the overlap of the Venn diagrams were ob-
tained using the hypergeometric test with a population size of 6389 genes.
SUPPLEMENTAL DATA
Supplemental Data include eight figures and nine tables and can be found with
this article onlineathttp://www.cell.com/supplemental/S0092-8674(09)00002-6.ACKNOWLEDGMENTS
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